Nataliya Kuptsova-Clarkson, MD

BeOne Medicines Ltd

Poster(s):

• 1426 - Efficacy and Safety of Zanubrutinib in a Fit Subgroup of Patients with Treatment-Naive Chronic Lymphocytic Leukemia: Post Hoc Analyses from the SEQUOIA Study